Literature DB >> 8978368

The pathobiology of biliary epithelia.

S K Roberts1, J Ludwig, N F Larusso.   

Abstract

Our understanding of the pathobiology of biliary epithelia is rapidly growing because of a surge of investigative activity. This became possible after suitable experimental models and techniques were developed with which to study cholangiocyte biology. Although the molecular mechanisms of bile formation by cholangiocytes and the role of these cells as a major cellular target in a variety of severe hepatobiliary diseases are currently being investigated, many questions remain unanswered, particularly regarding cholangiocellular functions, both in normal and abnormal conditions. As current experimental models become more refined, scientists with interests as diverse as cell biology and physiology, morphology, pharmacology, immunology, genetics, and oncology can be expected to further clarify the pathobiology of biliary epithelia.

Entities:  

Mesh:

Year:  1997        PMID: 8978368     DOI: 10.1016/s0016-5085(97)70244-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

Review 1.  Experimental models to study cholangiocyte biology.

Authors:  Pamela S Tietz; Xian-Ming Chen; Ai-Yu Gong; Robert C Huebert; Anatoliy Masyuk; Tatyana Masyuk; Patrick L Splinter; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 2.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Targeting PDGFR-β in Cholangiocarcinoma.

Authors:  Christian D Fingas; Joachim C Mertens; Nataliya Razumilava; Steven F Bronk; Alphonse E Sirica; Gregory J Gores
Journal:  Liver Int       Date:  2011-12-02       Impact factor: 5.828

Review 4.  Calcium signaling in the liver.

Authors:  Maria Jimena Amaya; Michael H Nathanson
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

5.  Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status.

Authors:  P Invernizzi; P M Battezzati; A Crosignani; P Zermiani; M Bignotto; N Del Papa; M Zuin; M Podda
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 6.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

7.  A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells.

Authors:  Christian D Fingas; Boris R A Blechacz; Rory L Smoot; Maria E Guicciardi; Justin Mott; Steve F Bronk; Nathan W Werneburg; Alphonse E Sirica; Gregory J Gores
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

Review 8.  Calcium signaling and the secretory activity of bile duct epithelia.

Authors:  Maria Jimena Amaya; Michael H Nathanson
Journal:  Cell Calcium       Date:  2014-02-12       Impact factor: 6.817

9.  Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis.

Authors:  Kazunori Shibao; Keiji Hirata; Marie E Robert; Michael H Nathanson
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

10.  Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.

Authors:  Christian D Fingas; Joachim C Mertens; Nataliya Razumilava; Svenja Sydor; Steven F Bronk; John D Christensen; Sumera H Rizvi; Ali Canbay; Jürgen W Treckmann; Andreas Paul; Alphonse E Sirica; Gregory J Gores
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.